Titanium dioxide
Anthelios (titanium dioxide) is a small molecule pharmaceutical. Titanium dioxide was first approved as Anthelios 20 on 2006-10-05.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Combinations
Anthelios
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Avobenzone
+
Ecamsule
+
Octocrylene
+
Titanium dioxide
Tradename
Company
Number
Date
Products
ANTHELIOS 20L'OréalN-021471 OTC2006-10-05
1 products, RLD, RS
ANTHELIOS 40L'OréalN-022009 OTC2008-03-31
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
OTC monograph final2013-01-07
100 % mineral spf mini setOTC monograph final2021-12-09
100% mineral body mist with green tea extract broad spectrum spf 50OTC monograph final2022-10-11
100% mineral broad spectrum sunscreen spf 30C2002632024-12-18
100% mineral broad spectrum sunscreen spf 50C2002632024-12-05
100% pure everywhere sunscreenOTC monograph not final2017-05-01
15hr cover lastingOTC monograph not final2015-09-21
1926 since derm acte 365 uv screenOTC monograph final2023-07-20
1926 since derm acte uv screen spf 30OTC monograph final2023-07-16
3lab perfect lite sunscreen spf 30 broad spectrumC2002632023-12-12
Show 1655 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
photosensitivity disordersD010787L57.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
136 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SunburnD013471EFO_0003958L5511
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTitanium dioxide
INN
Description
Titanium dioxide is a titanium oxide with the formula TiO2. A naturally occurring oxide sourced from ilmenite, rutile and anatase, it has a wide range of applications. It has a role as a food colouring.
Classification
Small molecule
Drug classquaternary ammonium derivatives
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID13463-67-7
RxCUI
ChEMBL IDCHEMBL1201136
ChEBI ID32234
PubChem CID26042
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 95,604 documents
View more details
Safety
Black-box Warning
Black-box warning for: Josie maran argan daily moisturizer spf47, Josie maran argan daily moisturizer spf47 protect and perfect, Josie maran argan daily moisturizer spf47 protect and perfect radiance, Luminizing moisture tint sunscreen broad spectrum spf 20, Matte moisture tint sunscreen broad spectrum spf 15, Minus-sol facial sun protection spf 30 plus ivory, Minus-sol facial sun protection spf 30 plus white, Skin tint fx
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
894 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use